was read the article
array:24 [ "pii" => "S2173574323000163" "issn" => "21735743" "doi" => "10.1016/j.reumae.2023.02.002" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "1618" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2022" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2023;19:136-42" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S1699258X22001218" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2022.04.001" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "1618" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2023;19:136-42" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Increased risk of stroke among patients with ankylosing spondylitis: A systematic review and meta-analysis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "136" "paginaFinal" => "142" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio respecto a un mayor riesgo de accidente cerebrovascular entre los pacientes con espondilitis anquilosante: revisión sistemática y metaanálisis" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2001 "Ancho" => 2833 "Tamanyo" => 351457 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Flow chart of included studies.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Akshaya Srikanth Bhagavathula, Barry L. Bentley, Benjamin Woolf, Thusharika D. Dissanayaka, Jamal Rahmani" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Akshaya Srikanth" "apellidos" => "Bhagavathula" ] 1 => array:2 [ "nombre" => "Barry L." "apellidos" => "Bentley" ] 2 => array:2 [ "nombre" => "Benjamin" "apellidos" => "Woolf" ] 3 => array:2 [ "nombre" => "Thusharika D." "apellidos" => "Dissanayaka" ] 4 => array:2 [ "nombre" => "Jamal" "apellidos" => "Rahmani" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574323000163" "doi" => "10.1016/j.reumae.2023.02.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574323000163?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X22001218?idApp=UINPBA00004M" "url" => "/1699258X/0000001900000003/v1_202303071056/S1699258X22001218/v1_202303071056/en/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2173574323000175" "issn" => "21735743" "doi" => "10.1016/j.reumae.2023.02.003" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "1605" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2023;19:143-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Peripheral T helper subset profiling in idiopathic inflammatory myositis: Proof of concept" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "143" "paginaFinal" => "149" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Perfil de subconjunto auxiliar T periférico en miositis inflamatoria idiopática: prueba de concepto" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 2013 "Ancho" => 2516 "Tamanyo" => 308637 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Representative dot plot comparing percentage of T cell subsets in various subsets of myositis (Dermatomyositis – DM, Polymyositis – PM, Overlap Myositis – OM, juvenile dermatomyositis – JDM with healthy controls (HC). (a) Th1 (b) Th17 (c) Th17.1 (d) T reg. Statistical test used is Kruskal–Wallis test.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Anamika Kumari Anuja, Pankti Mehta, Mantabya Kumar Singh, Harshit Singh, Alok Nath, Zia Hashim, Ajmal Khan, Mansi Gupta, Durga P. Misra, Vikas Agarwal, Latika Gupta" "autores" => array:11 [ 0 => array:2 [ "nombre" => "Anamika Kumari" "apellidos" => "Anuja" ] 1 => array:2 [ "nombre" => "Pankti" "apellidos" => "Mehta" ] 2 => array:2 [ "nombre" => "Mantabya Kumar" "apellidos" => "Singh" ] 3 => array:2 [ "nombre" => "Harshit" "apellidos" => "Singh" ] 4 => array:2 [ "nombre" => "Alok" "apellidos" => "Nath" ] 5 => array:2 [ "nombre" => "Zia" "apellidos" => "Hashim" ] 6 => array:2 [ "nombre" => "Ajmal" "apellidos" => "Khan" ] 7 => array:2 [ "nombre" => "Mansi" "apellidos" => "Gupta" ] 8 => array:2 [ "nombre" => "Durga P." "apellidos" => "Misra" ] 9 => array:2 [ "nombre" => "Vikas" "apellidos" => "Agarwal" ] 10 => array:2 [ "nombre" => "Latika" "apellidos" => "Gupta" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574323000175?idApp=UINPBA00004M" "url" => "/21735743/0000001900000003/v1_202303101257/S2173574323000175/v1_202303101257/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2173574323000151" "issn" => "21735743" "doi" => "10.1016/j.reumae.2023.02.001" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "1619" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2023;19:130-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Co-occurrence of familial Mediterranean fever with systemic lupus erythematosus in South Asian population" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "130" "paginaFinal" => "135" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Coocurrencia de fiebre mediterránea familiar con lupus eritematoso sistémico en la población del sudeste asiático" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1564 "Ancho" => 1515 "Tamanyo" => 95518 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Patient flowchart.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Muhammad Umar Farooq, Hasan Sohail, Muhammad Mohsin, Raafe Iqbal, Jahanzeb Malik, Uzma Ishaq" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Muhammad Umar" "apellidos" => "Farooq" ] 1 => array:2 [ "nombre" => "Hasan" "apellidos" => "Sohail" ] 2 => array:2 [ "nombre" => "Muhammad" "apellidos" => "Mohsin" ] 3 => array:2 [ "nombre" => "Raafe" "apellidos" => "Iqbal" ] 4 => array:2 [ "nombre" => "Jahanzeb" "apellidos" => "Malik" ] 5 => array:2 [ "nombre" => "Uzma" "apellidos" => "Ishaq" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574323000151?idApp=UINPBA00004M" "url" => "/21735743/0000001900000003/v1_202303101257/S2173574323000151/v1_202303101257/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Increased risk of stroke among patients with ankylosing spondylitis: A systematic review and meta-analysis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "136" "paginaFinal" => "142" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Akshaya Srikanth Bhagavathula, Barry L. Bentley, Benjamin Woolf, Thusharika D. Dissanayaka, Jamal Rahmani" "autores" => array:5 [ 0 => array:3 [ "nombre" => "Akshaya Srikanth" "apellidos" => "Bhagavathula" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Barry L." "apellidos" => "Bentley" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 2 => array:3 [ "nombre" => "Benjamin" "apellidos" => "Woolf" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 3 => array:3 [ "nombre" => "Thusharika D." "apellidos" => "Dissanayaka" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 4 => array:4 [ "nombre" => "Jamal" "apellidos" => "Rahmani" "email" => array:1 [ 0 => "jrahmani@sbmu.ac.ir" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:7 [ 0 => array:3 [ "entidad" => "Department of Social and Clinical Pharmacy, Faculty of Pharmacy at Hradec Kralove, Charles University, Hradec Kralove, Czech Republic" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Cardiff School of Technologies, Cardiff Metropolitan University, Cardiff, UK" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Collaboration for the Advancement of Sustainable Medical Innovation, University College London, London, UK" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Department of Psychological Sciences, University of Bristol, Bristol BS8 1TH, UK" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Department of Physiotherapy, Faculty of Allied Health Sciences, University of Peradeniya, Sri Lanka" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Department of Physiotherapy, Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran" "etiqueta" => "g" "identificador" => "aff0035" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio respecto a un mayor riesgo de accidente cerebrovascular entre los pacientes con espondilitis anquilosante: revisión sistemática y metaanálisis" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 2101 "Ancho" => 2995 "Tamanyo" => 191704 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Funnel plot of relation between ankylosing spondylitis and stroke.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Ankylosing spondylitis (AS) is a chronic inflammatory arthritis disease and one of the most common spondyloarthropathies.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">1,2</span></a> It typically occurs in the third decade of life, affecting males with an incidence rate approximately two to three times more likely to develop it than females.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">3</span></a> The condition mainly affects axial vertebrae of the spine, the sacroiliac joints, and surrounding joints, affecting extra-articular organs to a much lesser extent.<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">4</span></a> The clinical presentation of AS includes chronic pain, impaired physical mobility, and various functional disabilities.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">5</span></a> Additionally, specific diseases have been identified to be associated with AS, including uveitis, aortic and valve disease, and IgA nephropathy.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">1,6,7</span></a> In general, AS results in severe impairment of spinal mobility, physical function, and thereby the quality of life.</p><p id="par0010" class="elsevierStylePara elsevierViewall">AS cases are at increased risk of dying from cardiovascular disease (CVD).<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">8</span></a> Given this association, the European Alliance of Associations for Rheumatology (EULAR) has recommended annual CVD risk assessment and risk management for patients with AS.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">9</span></a> Findings from previous systematic reviews and meta-analyses have demonstrated that AS patients have a higher incidence of myocardial infarction than controls, which could be due to low high-density lipoprotein (HDL) cholesterol levels or systemic inflammation.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">10</span></a> Additionally, this study reports a significant risk of stroke linked to AS compared to control. A recent study by Trömmer et al.,<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">11</span></a> showed that AS was tendentially associated with stroke and indicated that this increased risk was primarily within older populations (>60 years). Recently, two updated reviews showed a significant risk of both myocardial infarction and stroke related to AS.<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">12,13</span></a> Following these reviews, several new studies have emerged concerning adverse cardiovascular events and stroke; however, findings from individual studies provided variable results on the association between AS and cerebrovascular events. Therefore, a comprehensive review and meta-analysis was conducted to determine the relationship between AS and the risk of stroke.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Search strategy</span><p id="par0015" class="elsevierStylePara elsevierViewall">This systematic review and meta-analysis were conducted following PRISMA guidelines.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">14</span></a> A literature search was conducted using MeSH and key terms in PubMed/MEDLINE, Scopus, and Web of Science to identify relevant articles published in the English language from inception to December 2021. References from the relevant articles were also screened for any additional studies. The detailed search strategy is reported in <a class="elsevierStyleCrossRef" href="#sec0090">Supplementary Table 1</a>.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Inclusion criteria</span><p id="par0020" class="elsevierStylePara elsevierViewall">To be included, studies must: (1) evaluate the risk of stroke among patients with ankylosing spondylitis; (2) report results with appropriate statistical parameters (odds ratio (ORs), Risk ratio (RRs), or Hazard ratio (HRs)); (3) use an appropriate design to conduct the study (case–control, controlled trial, or cohort).</p><p id="par0025" class="elsevierStylePara elsevierViewall">Studies that did not include data on the association between AS and the risk of stroke were not considered. This meta-analysis also excluded review articles, in vitro research, editorials, commentaries, case reports/series, letters and studies with preliminary or insufficient data.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Data extraction and quality assessment</span><p id="par0030" class="elsevierStylePara elsevierViewall">Studies were screened in steps: (1) title and abstract screening, and (2) the full-text screening, using predesigned extraction forms. Two reviewers extracted the data, with subsequent double-checking by an additional reviewer. A third author was consulted when discrepancies occurred. The Newcastle-Ottawa Scale (NOS) for nonrandomized studies was used to assess the quality of included studies.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">15</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Statistical analysis</span><p id="par0035" class="elsevierStylePara elsevierViewall">In each included study, fully adjusted models were used as corresponding estimates. The pooled results are presented as HR with corresponding 95% confidence intervals (CIs). Heterogeneity among the results was evaluated with Cochran's <span class="elsevierStyleItalic">Q</span> test and <span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span> statistics; where the <span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span> showed no evidence of heterogeneity (<span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>25%), analyses were conducted using the inverse-variance fixed effects model for pooling the studies, whereas when <span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span><span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>25%, the DerSimonian and Laird random-effects model was used.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">16</span></a> Subgroup analyses and meta-regression analyses were performed to identify the source of heterogeneity, and sensitivity analysis was performed to investigate the effect of each study on pooled estimates. The publication bias was determined by visual inspection of funnel plots, Egger's regression test, and Begg's correlation test. A <span class="elsevierStyleItalic">P</span>-value less than 0.05 was considered statistically significant. All the statistical tests were conducted using STATA 14.0 (StataCorp LP, College Station, TX, USA).</p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Results</span><p id="par0040" class="elsevierStylePara elsevierViewall">In total, 341 articles were retrieved in the initial search. Of these 111 duplicate records were removed, and 203 articles were excluded following title and abstract screening. 21 studies were screened in the full-text evaluation following the inclusion criteria; 16 irrelevant records were excluded for various reasons (details presented in <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Finally, 11 studies met the inclusion criteria and were included in the systematic review and meta-analysis.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">5,11,17–25</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Study characteristics and quality assessment</span><p id="par0045" class="elsevierStylePara elsevierViewall">Those studies that met the inclusion criteria are listed in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>, along with their study characteristics. These studies were published from 2006 to 2021 with 1,741,532 participants. One study from Germany,<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">11</span></a> Korea,<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">17</span></a> UK,<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">23</span></a> Canada,<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">24</span></a> USA,<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">25</span></a> two studies from Sweden,<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">18,22</span></a> and four from Taiwan.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">5,19–21</span></a> Eight studies followed a cohort design,<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">11,17–20,22–24</span></a> with the remaining being case–control studies.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">5,21,25</span></a> All studies contained both men and women and had an average follow-up length of 11 years. <a class="elsevierStyleCrossRef" href="#sec0090">Supplementary Table 2</a> provides the quality assessment of included studies, with most exhibiting good quality (NOS score ≥7).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Association of ankylosing spondylitis with stroke</span><p id="par0050" class="elsevierStylePara elsevierViewall">Eleven studies<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">5,11,17–25</span></a> comprised 1.74 million subjects, reported around 26,000 cases of stroke. The pooled analyses of case–control and cohort studies showed that the overall risk of stroke is significantly higher (56%) in patients with ankylosing spondylitis (HR: 1.56, 95% CI: 1.33–1.79, <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001; <span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>94.8%) versus controls (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>). Moreover, when studies were assessed based on the type of stroke, results indicated that the risk of ischemic stroke was 46% in patients with ankylosing spondylitis (HR: 1.46, 95% CI: 1.23–1.68) (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>) with only one study<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">21</span></a> reporting a higher risk of hemorrhagic stroke in patients with ankylosing spondylitis (HR: 2.72, 95% CI: 2.41–3.03).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0055" class="elsevierStylePara elsevierViewall">Meta-regression based on length of follow-up showed no relation with stroke (Coef<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>−0.0010, <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.951) (<a class="elsevierStyleCrossRef" href="#sec0090">Supplemental Figure 1</a>). Subgroup analysis based on study location showed no difference in reported risk of stroke among ankylosing spondylitis in studies conducted in North America (2 studies): 1.45 (95% CI: 1.01–1.89), Asia (5 studies): 1.60 (95% CI: 1.18–2.01), and Europe (5 studies): 1.57 (95% CI: 1.02–2.12), more details in <a class="elsevierStyleCrossRef" href="#sec0090">Supplemental Figure 2</a>. Furthermore, studies stratified based on year of publication indicated studies conducted between 2006 and 2012 had a pooled HR of 1.47 (95% CI: 1.13–1.81) versus studies conducted after 2012 (HR: 1.66, 95% CI: 1.33–1.99) (<a class="elsevierStyleCrossRef" href="#sec0090">Supplemental Figure 3</a>).</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Publication bias and sensitivity analysis</span><p id="par0060" class="elsevierStylePara elsevierViewall">The funnel plots provided in <a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a> indicate no asymmetry between the included studies and the Begg's <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.210 and Egger's test <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.491 confirmed a low risk of publication bias among the included studies. Sensitivity analysis is provided in <a class="elsevierStyleCrossRef" href="#sec0090">Supplemental Figure 4</a>, and shows no differences beyond of the 95% CI limitation for calculated combined results.</p><elsevierMultimedia ident="fig0020"></elsevierMultimedia></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Discussion</span><p id="par0065" class="elsevierStylePara elsevierViewall">A significant body of literature suggests that chronic systemic inflammation promotes clot formation by interfering with physiological hemostasis and inducing hypercoagulability, which can result in cerebrovascular events.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">1,4,6,7</span></a> In this context, epidemiological studies have reported an increased risk of stroke in patients with ankylosing spondylitis (AS),<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">18,20,24</span></a> while other investigations did not identify any increased risk of stroke in patients with AS.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">5,22</span></a> This study sought to elucidate the association between AS and stroke development by combining the data of over 1.6 million participants from epidemiological studies, to provide an important update on the risk of stroke among patients with AS. Our data support the hypothesis that AS is a significant risk factor for stroke with an HR of 1.56 (95% CI: 1.33–1.79) relative to controls. The increased risk of stroke among AS patients could be due to a number of underlying risk factors, such as hypertension and traditional use of anti-inflammatory drugs as first-line therapies, which may increase the risk of cerebrovascular events.<a class="elsevierStyleCrossRefs" href="#bib0315"><span class="elsevierStyleSup">26–29</span></a> Moreover, AS patients typically have a worse cardiovascular (CV) profile than controls, a higher incidence of metabolic syndrome – itself a risk factor for CVD<a class="elsevierStyleCrossRefs" href="#bib0335"><span class="elsevierStyleSup">30–32</span></a> – and are more likely to receive a diagnosis of diabetes and hypertension.<a class="elsevierStyleCrossRefs" href="#bib0330"><span class="elsevierStyleSup">29,33,34</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">A limited body of literature exists on the risk of developing hemorrhagic stroke in AS populations, although a couple of reported results exist.<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">18,22</span></a> On the other hand, the hazards of ischemic stroke for AS support an association with an elevated risk. Studies stratified based on study design showed a consistent 62% increase in the risk of stroke events reported in cohort studies and 39% in case–control studies.<a class="elsevierStyleCrossRefs" href="#bib0360"><span class="elsevierStyleSup">35,36</span></a></p><p id="par0075" class="elsevierStylePara elsevierViewall">Exposure to higher does of non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of adverse cardiovascular events, with their use in AS patients being a potential confounder; however, it is difficult to separate the biological impact of NSAIDs in AS patients, and it remains controversial whether these agents, particularly COX-2 inhibitors, are associated with an increased risk of stroke. A meta-analysis of 280 trials on NSAIDs vs. placebo showed little evidence that NSAIDs significantly increased the risk of stroke in these patients.<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">37</span></a> Therefore, the use of NSAIDs and risk of stroke requires further elucidation, preferably through longitudinal studies.</p><p id="par0080" class="elsevierStylePara elsevierViewall">By including a range of studies from different patient populations, with varying risk factors and study methodologies, it is possible to estimate the risk of stroke observed in AS. Meta-regression analysis relies on variability in the magnitude of effect across studies, and due to modest differences between the study groups, did not detect the occurrence of stroke in AS patients with the duration of time. Thus, our results suggest an independent association of increased stroke risk with AS, although the underlying reasons for this discrepancy are not clear. In contrast, our sensitivity analysis illustrated that most of the studies are beyond the limit of 95% CI of the combined results for each of the included studies. Egger's and Begg's tests did not identify any significant publication bias and showed symmetric funnel plots.</p><p id="par0085" class="elsevierStylePara elsevierViewall">This study has several limitations: First, only two studies reported the risk of hemorrhagic stroke in AS and it can lead to non-comprehensive results. Second, variations in the sample sizes of the included studies and their study designs affect their interpretation, thus caution should be taken when drawing conclusions from the combined results. Differences in the patient characteristics may result in higher heterogeneity, which may confound with age, sex, or other factors that increase the risk reported for AS patients. Lastly, the outcomes reported by each study may have a different definition which could affect the pool estimates in the meta-analysis. Despite these limitations, our comprehensive literature review provides robust evidence of the association between AS and stroke events by integrating results of 7 large cohorts,<a class="elsevierStyleCrossRefs" href="#bib0270"><span class="elsevierStyleSup">17,22–24</span></a> and 3 case–control studies.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">5,21,25</span></a> The mean follow-up duration in cohort studies was 11 years and reported an overall 2.02% of stroke cases in 1.74 million AS subjects.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conclusion</span><p id="par0090" class="elsevierStylePara elsevierViewall">This study suggests that ankylosing spondylitis significantly increases the risk of stroke. Management of cerebrovascular risk factors and control of systemic inflammation should be considered in patients with ankylosing spondylitis.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Data availability</span><p id="par0095" class="elsevierStylePara elsevierViewall">Available on request.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Funding</span><p id="par0100" class="elsevierStylePara elsevierViewall">No fund.</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Author contributions</span><p id="par0105" class="elsevierStylePara elsevierViewall">Analysis, JR; Writing, ASB, BLB, BW and TDD; Screening and Data extracting, JR and ASB; Idea and Manuscript revision, JR; Revision, ASB, BLB, and BW.</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Conflict of interest</span><p id="par0110" class="elsevierStylePara elsevierViewall">The authors declare no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:14 [ 0 => array:3 [ "identificador" => "xres1860394" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusion" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1617089" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1860393" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Antecedentes" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1617088" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Methods" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Search strategy" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Inclusion criteria" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Data extraction and quality assessment" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Statistical analysis" ] ] ] 6 => array:3 [ "identificador" => "sec0035" "titulo" => "Results" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0040" "titulo" => "Study characteristics and quality assessment" ] 1 => array:2 [ "identificador" => "sec0045" "titulo" => "Association of ankylosing spondylitis with stroke" ] 2 => array:2 [ "identificador" => "sec0050" "titulo" => "Publication bias and sensitivity analysis" ] ] ] 7 => array:2 [ "identificador" => "sec0055" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0060" "titulo" => "Conclusion" ] 9 => array:2 [ "identificador" => "sec0065" "titulo" => "Data availability" ] 10 => array:2 [ "identificador" => "sec0070" "titulo" => "Funding" ] 11 => array:2 [ "identificador" => "sec0075" "titulo" => "Author contributions" ] 12 => array:2 [ "identificador" => "sec0080" "titulo" => "Conflict of interest" ] 13 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2021-09-09" "fechaAceptado" => "2022-04-28" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1617089" "palabras" => array:6 [ 0 => "Ankylosing spondylitis" 1 => "Stroke" 2 => "Cerebrovascular accident" 3 => "Risk" 4 => "Hazard ratio" 5 => "Systematic review meta-analysis" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1617088" "palabras" => array:6 [ 0 => "Espondilitis anquilosante" 1 => "Ictus" 2 => "Accidente cerebrovascular" 3 => "Riesgo" 4 => "Relación de peligro" 5 => "Revisión sistemática de metaanálisis" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Ankylosing spondylitis is a chronic inflammatory disease that is associated with adverse cardiovascular events. This study aimed to determine the relationship between ankylosing spondylitis and the risk of stroke.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A systematic literature search in PubMed/MEDLINE, Scopus, and Web of Science were conducted from inception to December 2021 to identify relevant articles investigating the risk of stroke in patients with ankylosing spondylitis. A random-effects model (DerSimonian and Laird) was used to estimate a pooled hazard ratio (HR) and 95% confidence intervals (CI). Meta-regression based on the length of follow-up and subgroup analysis based on the type of stroke, study location, and year of publication to investigate the source of heterogeneity.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">A total of eleven studies comprising 1.7 million participants were included in this study. Pooled analysis showed a significantly increased stroke risk (56%) among patients with ankylosing spondylitis (HR: 1.56, 95% CI 1.33–1.79). Subgroup analysis revealed a higher risk of ischemic stroke among patients with ankylosing spondylitis (HR: 1.46, 95% CI: 1.23–1.68). However, meta-regression analysis showed no association between the duration of ankylosing spondylitis and stroke incidence (Coef<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>−0.0010, <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.951).</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusion</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">This study reveals that ankylosing spondylitis was associated with an increased risk of suffering a stroke. Management of cerebrovascular risk factors and the control of systemic inflammation should be considered in patients with ankylosing spondylitis.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusion" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Antecedentes</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">La espondilitis anquilosante es una enfermedad inflamatoria crónica que se asocia con eventos cardiovasculares adversos. Este estudio tuvo como objetivo determinar la relación entre la espondilitis anquilosante y el riesgo de accidente cerebrovascular.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Métodos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Se realizó una búsqueda sistemática de la literatura en PubMed/Medline, Scopus y Web of Science a partir de diciembre de 2021 para identificar los artículos relevantes que investigan el riesgo de accidente cerebrovascular en pacientes con espondilitis anquilosante. Se usó un modelo de efectos aleatorios (Dersimonian y Laird) para estimar una relación de peligro agrupada (HR) e intervalos de confianza (IC) del 95%. Meta-regresión basada en la duración del seguimiento y análisis de subgrupos basados en el tipo de accidente cerebrovascular, la ubicación de estudio y año de publicación para investigar la fuente de heterogeneidad.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Un total de 11 estudios que comprenden 1,7 millones de participantes, se incluyeron en este estudio. El análisis agrupado mostró un riesgo de accidente cerebrovascular significativamente aumentado (56%) entre los pacientes con espondilitis anquilosante (HR: 1,56; IC 95%: 1,33-1,79). El análisis de los subgrupos reveló un mayor riesgo de accidente cerebrovascular isquémico entre los pacientes con espondilitis anquilosante (HR: 1,46; IC 95%: 1,23-1,68). Sin embargo, el análisis de meta-regresión no mostró ninguna asociación entre la duración de la espondilitis anquilosante y la incidencia de accidentes cerebrovasculares (coef<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>−0,0010; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0,951).</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Este estudio revela que la espondilitis anquilosante se asocia a un mayor riesgo de sufrir un accidente cerebrovascular. La gestión de los factores de riesgo cerebrovasculares y el control de la inflamación sistémica deben considerarse en pacientes con espondilitis anquilosante.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Antecedentes" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] ] "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:1 [ 0 => array:4 [ "apendice" => "<p id="par0120" class="elsevierStylePara elsevierViewall">The following are the supplementary data to this article:<elsevierMultimedia ident="upi0005"></elsevierMultimedia></p>" "etiqueta" => "Appendix A" "titulo" => "Supplementary data" "identificador" => "sec0090" ] ] ] ] "multimedia" => array:6 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2010 "Ancho" => 2842 "Tamanyo" => 424860 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Flow chart of included studies.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2297 "Ancho" => 2502 "Tamanyo" => 412314 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Meta-analysis of relation between ankylosing spondylitis and stroke.</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 2592 "Ancho" => 2515 "Tamanyo" => 411748 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Association between ankylosing spondylitis and type of stroke.</p>" ] ] 3 => array:7 [ "identificador" => "fig0020" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 2101 "Ancho" => 2995 "Tamanyo" => 191704 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Funnel plot of relation between ankylosing spondylitis and stroke.</p>" ] ] 4 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:1 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Study \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Year \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Country \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Design \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Study name or data \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Age \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Participants (<span class="elsevierStyleItalic">n</span>) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Case (<span class="elsevierStyleItalic">n</span>) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Follow-up (year) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Stroke type (ischemic/hemorrhagic) \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Trömmer K. et al. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2021 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Germany \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cohort \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IQVID (2000–2015) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">54.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">58,212 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">154 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Both \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="